グロボトリアオシルセラミド(Gb3)豚赤血球由来

グロボトリアオシルセラミド(Gb3)豚赤血球由来 化学構造式
71965-57-6
CAS番号.
71965-57-6
化学名:
グロボトリアオシルセラミド(Gb3)豚赤血球由来
别名:
セラミドトリヘキソシド;1-O-[4-O-(4-O-α-D-ガラクトピラノシル-β-D-ガラクトピラノシル)-β-D-グルコピラノシル]セラミド
英語名:
GLOBOTRIAOSYLCERAMIDE PORCINE
英語别名:
Cd77 antigen;Globotriosylceramide;Globotriasoyl ceramide;Gal-1-4-gal-1-4-glc-cer;Gb3 globotriaosylceramide;Ceramide trihexoside, CTH;GLOBOTRIASYLCERAMIDE, PORCINE;Trihexosylceramide (d18:1/18:0);Trihexosylceramide (d18:1/25:0);Trihexosylceramide (d18:1/22:0)
CBNumber:
CB0497406
化学式:
C37H66NO18
分子量:
0
MOL File:
71965-57-6.mol

グロボトリアオシルセラミド(Gb3)豚赤血球由来 物理性質

貯蔵温度 :
−20°C
溶解性:
DMSO: Soluble; Methanol: Soluble (warmed)
外見 :
凍結乾燥粉末

安全性情報

WGK Germany  3

グロボトリアオシルセラミド(Gb3)豚赤血球由来 価格 もっと(1)

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入
ナカライテスク株式会社(Nacalai) 02446-91 グロボトリアオシルセラミド(Gb3)豚赤血球由来
Globotriaosylceramide (Gb3) from Porcine Erythrocyte
71965-57-6 1MG ¥31300 2023-06-01 購入

グロボトリアオシルセラミド(Gb3)豚赤血球由来 化学特性,用途語,生産方法

グロボトリアオシルセラミド(Gb3)豚赤血球由来 上流と下流の製品情報

原材料

準備製品


グロボトリアオシルセラミド(Gb3)豚赤血球由来 生産企業

Global( 17)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
BOC Sciences
+1-631-485-4226
inquiry@bocsci.com United States 19553 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 32161 58
Alfa Chemistry

Info@alfa-chemistry.com United States 24072 58
Aladdin Scientific
+1-+1(833)-552-7181
sales@aladdinsci.com United States 57505 58
Shanghai Aladdin Bio-Chem Technology Co.,LTD 400-400-6206333 18521732826
market@aladdin-e.com China 25003 65
Yichang Zhongyitai Trading Co., Ltd. 0717-6449896 13886658719
root@zhongyitai.com China 1977 58
Shanghai Hongye Biotechnology Co. Ltd 400-9205774
sales@glpbio.cn China 6777 58
BOC Sciences 16314854226
inquiry@bocsci.com United States 9713 58
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767
sales@chemegen.com China 11218 58
TargetMol Chemicals Inc. 4008200310
marketing@tsbiochem.com China 24644 58

71965-57-6(グロボトリアオシルセラミド(Gb3)豚赤血球由来)キーワード:


  • 71965-57-6
  • Trihexosylceramide (d18:1/18:0)
  • N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-5-((2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)icosanamide
  • Trihexosylceramide (d18:1/20:0)
  • N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-5-((2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)docosanamide
  • Trihexosylceramide (d18:1/22:0)
  • N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-5-((2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)tetracosanamide
  • Trihexosylceramide (d18:1/24:0)
  • (Z)-N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-5-((2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)tetracos-15-enamide
  • Trihexosylceramide (d18:1/24:1(15Z))
  • N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-5-((2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)pentacosanamide
  • Trihexosylceramide (d18:1/25:0)
  • (Z)-N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-5-((2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)hexacos-17-enamide
  • Trihexosylceramide (d18:1/26:1(17Z))
  • (Z)-N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-5-((2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)octadec-9-enamide
  • Trihexosylceramide (d18:1/9Z-18:1)
  • GLOBOTRIAOSYLCERAMIDE FROM HUMAN*ERYTHROCYTES
  • GLOBOTRIASYLCERAMIDE, PORCINE
  • N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-5-((2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)dodecanamide
  • Trihexosylceramide (d18:1/12:0)
  • N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-5-((2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)hexadecanamide
  • Trihexosylceramide (d18:1/16:0)
  • N-((2S,3R,E)-1-((2R,3R,4R,5S,6R)-5-((2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-3-hydroxyoctadec-4-en-2-yl)octadecanamide
  • Ceramide trihexoside, CTH
  • Burkitt'S lymphoma antigen, bla-cd77
  • Cd77 antigen
  • Gal-1-4-gal-1-4-glc-cer
  • Galactosyl(alpha1-4)galactosyl(beta1-4)glucosylceramide
  • Ganglioside ga3, o-alpha-D-galactopyranosyl-(1-4B)-
  • Gb3 globotriaosylceramide
  • Globotriasoyl ceramide
  • セラミドトリヘキソシド
  • 1-O-[4-O-(4-O-α-D-ガラクトピラノシル-β-D-ガラクトピラノシル)-β-D-グルコピラノシル]セラミド
Copyright 2017 © ChemicalBook. All rights reserved